FBXW7, as a critical tumor suppressor, targets various substrates for proteasome-mediated degradation of oncoproteins, including cyclin E, c-Myc, Mcl-1, mTOR, Jun, and Notch (Yeh et al, 2018). Here, MYC is linked to neoplasm.